Inventor · disambiguated record
Torsten Herbertz
Also filed as: HERBERTZ TORSTEN
16 granted patents·8 pending applications·115 citations·filing 2003–2024
92Inventor score
Top patents by PatentIndex Score
24 records- 0197US10336722B2Tetrahydroquinoline compositions as BET bromodomain inhibitorsFORMA THERAPEUTICS INC·Filed 2018·Granted Jul 2, 2019·22 cites·47 claims
- 0297US9422281B2Benzopiperazine compositions as BET bromodomain inhibitorsFORMA THERAPEUTICS INC·Filed 2014·Granted Aug 23, 2016·25 cites·35 claims
- 0396US11111229B2Tetrahydroquinoline compositions as BET bromodomain inhibitorsFORMA THERAPEUTICS INC·Filed 2020·Granted Sep 7, 2021·4 cites·22 claims
- 0496US10377769B2Benzopiperazine compositions as BET bromodomain inhibitorsFORMA THERAPEUTICS INC·Filed 2018·Granted Aug 13, 2019·10 cites·28 claims
- 0596US9388161B2Tetrahydroquinoline compositions as BET bromodomain inhibitorsFORMA THERAPEUTICS INC·Filed 2014·Granted Jul 12, 2016·34 cites·44 claims
- 0694US10870648B2Inhibiting CREB binding protein (CBP)FORMA THERAPEUTICS INC·Filed 2019·Granted Dec 22, 2020·8 cites·24 claims
- 0794US10611750B2Tetrahydroquinoline compositions as bet bromodomain inhibitorsFORMA THERAPEUTICS INC·Filed 2018·Granted Apr 7, 2020·7 cites·38 claims
- 0891US11254674B2Inhibiting CREB binding protein (CBP)FORMA THERAPEUTICS INC·Filed 2020·Granted Feb 22, 2022·2 cites·21 claims
- 0987US10703764B2Benzopiperazine compositions as BET bromodomain inhibitorsFORMA THERAPEUTICS INC·Filed 2019·Granted Jul 7, 2020·2 cites·19 claims
- 1079US2024150349A1Tetrahydro-imidazo quinoline compositions as cbp/p300 inhibitorsFORMA THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 1178US11292791B2Tetrahydro-imidazo quinoline compositions as CBP/P300 inhibitorsFORMA THERAPEUTICS INC·Filed 2018·Granted Apr 5, 2022·1 cites·20 claims
- 1277US2025188079A1Inhibiting cyclic amp-responsive element-binding protein (creb)FORMA THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 1376US2023061891A1Tetrahydroquinoline compositions as bet bromodomain inhibitorsFORMA THERAPEUTICS INC·Filed 2021·Application pending·0 cites
- 1474US12378242B2Inhibiting CREB binding protein (CBP)FORMA THERAPEUTICS INC·Filed 2022·Granted Aug 5, 2025·0 cites·19 claims
- 1574US11084831B1Benzopiperazine compositions as BET bromodomain inhibitorsFORMA THERAPEUTICS INC·Filed 2020·Granted Aug 10, 2021·0 cites·14 claims
- 1673US11787803B2Tetrahydro-imidazo quinoline compositions as CBP/P300 inhibitorsFORMA THERAPEUTICS INC·Filed 2022·Granted Oct 17, 2023·0 cites·20 claims
- 1765US2016257699A1Benzopiperazine compositions as bet bromodomain inhibitorsFORMA THERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 1862US12351577B2Inhibiting cyclic AMP-responsive element-binding protein (CREB)FORMA THERAPEUTICS INC·Filed 2020·Granted Jul 8, 2025·0 cites·19 claims
- 1959US2016257692A1Tetrahydroquinoline compositions as bet bromodomain inhibitorsFORMA THERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 2052US9321739B2Compounds, compositions and methods for treating or preventing pneumovirus infection and associated diseasesRYS DAVID J·Filed 2011·Granted Apr 26, 2016·0 cites·21 claims
- 2147US8119672B2Compounds, compositions and methods for treating or preventing pneumovirus infection and associated diseasesRYS DAVID J·Filed 2003·Granted Feb 21, 2012·0 cites·15 claims
- 2243US2016256458A1Benzopiperazine compositions as bet bromodomain inhibitorsFORMA THERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 2343US2016256448A1Tetrahydroquinoline compositions as bet bromodomain inhibitorsFORMA THERAPEUTICS INC·Filed 2016·Application pending·0 cites
- 2441US2007219212A1Pyranouidole Derivatives and the Use Thereof for the Treatment of Hepatitis C Virus Infection or DiseaseCONDON STEPHEN M·Filed 2005·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →